BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 15313947)

  • 21. Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus.
    Sidhu JS; Cowan D; Kaski JC
    Am J Cardiol; 2004 Jul; 94(2):151-6. PubMed ID: 15246889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluvastatin blunts the effect of a high-fat meal on plasma triglyceride and high-sensitivity C-reactive protein concentrations in patients at high risk for cardiovascular events.
    Liu L; Zhao SP; Hu M; Li JX
    Coron Artery Dis; 2007 Sep; 18(6):489-93. PubMed ID: 17700222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xuezhikang decreases serum lipoprotein(a) and C-reactive protein concentrations in patients with coronary heart disease.
    Liu L; Zhao SP; Cheng YC; Li YL
    Clin Chem; 2003 Aug; 49(8):1347-52. PubMed ID: 12881451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The acute effect of various glycemic index dietary carbohydrates on endothelial function in nondiabetic overweight and obese subjects.
    Lavi T; Karasik A; Koren-Morag N; Kanety H; Feinberg MS; Shechter M
    J Am Coll Cardiol; 2009 Jun; 53(24):2283-7. PubMed ID: 19520253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artichoke juice improves endothelial function in hyperlipemia.
    Lupattelli G; Marchesi S; Lombardini R; Roscini AR; Trinca F; Gemelli F; Vaudo G; Mannarino E
    Life Sci; 2004 Dec; 76(7):775-82. PubMed ID: 15581909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of withdrawal of Xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with coronary artery disease.
    Hu CL; Li YB; Tang YH; Chen JB; Liu J; Tang QZ; Zhang QH; Huang CX
    Cardiovasc Drugs Ther; 2006 Jun; 20(3):185-91. PubMed ID: 16775668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the postprandial lipid metabolism: use of a 3-point test.
    Guerci B; Paul JL; Hadjadj S; Durlach V; Vergès B; Attia N; Girard-Globa A; Drouin P
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):449-57. PubMed ID: 11547218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postprandial hypertriglyceridemia associated with inflammatory response and procoagulant state after a high-fat meal in hypertensive patients.
    Liu L; Zhao SP; Wen T; Zhou HN; Hu M; Li JX
    Coron Artery Dis; 2008 May; 19(3):145-51. PubMed ID: 18418230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.
    Olijhoek JK; Hajer GR; van der Graaf Y; Dallinga-Thie GM; Visseren FL
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):145-50. PubMed ID: 18670365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of intensive lifestyle changes on endothelial function and on inflammatory markers of atherosclerosis.
    Dod HS; Bhardwaj R; Sajja V; Weidner G; Hobbs GR; Konat GW; Manivannan S; Gharib W; Warden BE; Nanda NC; Beto RJ; Ornish D; Jain AC
    Am J Cardiol; 2010 Feb; 105(3):362-7. PubMed ID: 20102949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.
    Shechter M; Issachar A; Marai I; Koren-Morag N; Freinark D; Shahar Y; Shechter A; Feinberg MS
    Int J Cardiol; 2009 May; 134(1):52-8. PubMed ID: 18479768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trans monounsaturated fatty acids and saturated fatty acids have similar effects on postprandial flow-mediated vasodilation.
    de Roos NM; Siebelink E; Bots ML; van Tol A; Schouten EG; Katan MB
    Eur J Clin Nutr; 2002 Jul; 56(7):674-9. PubMed ID: 12080409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension.
    Konduracka E; Galicka-Latala D; Cieslik G; Rostoff P; Fedak D; Sieradzki J; Naskalski J; Piwowarska W
    Diabetes Obes Metab; 2008 Sep; 10(9):719-25. PubMed ID: 17941871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of ciprofibrate on the endothelial dysfunction of patients with combined dyslipidemia].
    Kovács I; Tarján J; Császár A
    Orv Hetil; 2001 Apr; 142(15):775-9. PubMed ID: 11367862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH; Bays H; Rhyne J; Stein E; Rotenberg K; Doyle R
    Clin Ther; 2005 Jun; 27(6):715-27. PubMed ID: 16117978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD.
    Dogra G; Irish A; Chan D; Watts G
    Am J Kidney Dis; 2007 Jun; 49(6):776-85. PubMed ID: 17533020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
    Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
    Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
    Hong XZ; Li LD; Wu LM
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction.
    Yunoki K; Nakamura K; Miyoshi T; Enko K; Kohno K; Morita H; Kusano KF; Ito H
    Atherosclerosis; 2011 Aug; 217(2):486-91. PubMed ID: 21592480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.